Allozymes

About Allozymes

Allozymes is a biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.

  • Country/Region:
    France
  • On CPHI since:
    2025
  • Employees:
    25 - 49
Company types
Academic/Research
Engineering
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Laboratory Services
Pharmaceutical Company (innovator finished products)
Contact info

Products from Allozymes (3)

  • Glucose Dehydrogenases

    Product Glucose Dehydrogenases

    Efficient Cofactor Recycling, Unmatched StabilityMeet our high-performance glucose dehydrogenase, the ideal partner for NAD(P)H regeneration in biocatalytic processes. 
    Engineered for robust activity across a wide range of temperatures, pH levels, and high concentrations of co-solvents like DMSO, i...
  • Transaminases

    Product Transaminases

    Discover our versatile panel of transaminases, expertly engineered for bulky ketone transformations. Whether you're working at milligram scale for discovery or kilogram scale for production, our enzymes deliver high selectivity, efficiency, and scalability.

    ✅ Tailored for sterically demanding su...
  • Unspecific Peroxygenases UPOs

    Product Unspecific Peroxygenases UPOs

    Unspecific peroxygenases (UPOs) are next-generation biocatalysts that use only hydrogen peroxide to perform selective oxyfunctionalization—such as hydroxylation and epoxidation—on a wide range of molecules. They deliver P450-like versatility without the need for costly cofactors or complex electron-transfe...

Allozymes Resources (2)

  • News Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology

    Allozymes has partnered with Adisseo, a global leader in animal nutrition, to develop sustainable bioprocesses for feed ingredients. The collaboration begins with a new enzymatic process for methionine, leveraging Allozymes’ microfluidics technology to deliver faster, greener alternatives to traditional production.
  • Brochure Your End-to-End Enzyme Partner — Allozymes One-Pager

    Learn how Allozymes supports your innovation journey with tailored enzyme discovery, engineering, and supply. Powered by our proprietary microfluidics platform and ultra-high-throughput screening, we rapidly analyze millions of enzyme variants and scale them in-house to 150 L pilot bioreactors. This one-pager highlights our technology, services, and real-world applications across pharma, chemicals, and life sciences.